Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 May 2006

Thorax. Published Online First: 3 March 2006. doi:10.1136/thx.2005.052456
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society.

Papers

Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study

Kevin Mortimer 1*, Laila J Tata 1, Chris J P Smith 1, Joe West 1, Tim W Harrison 1, Anne Tattersfield 1 and Richard Hubbard 1

1 University of Nottingham, United Kingdom

* To whom correspondence should be addressed. E-mail: kevinmortimer{at}msn.com.

Accepted 26 January 2006


Abstract

Background: Adrenal insufficiency, a well-recognised complication of treatment with oral corticosteroids, has been described in association with inhaled corticosteroid use in over 60 case reports. The risk of adrenal insufficiency in people prescribed an oral or inhaled corticosteroid in the general population is not known. Objective. To quantify the association between adrenal insufficiency and oral and inhaled corticosteroid exposure.

Methods: Case-control study using computerized general practice data from The Health Improvement Network.

Results: We identified 154 cases of adrenal insufficiency and 870 controls from a cohort of 2.4 million people. There was a dose-related increased risk of adrenal insufficiency in people prescribed an oral corticosteroid with an odds ratio of 2.0 (95% CI 1.6 to 2.5) per course of treatment per year. Adrenal insufficiency was associated with a prescription for an inhaled corticosteroid within the 90 days prior to the diagnosis with an odds ratio of 3.4 (95% CI 1.9 to 5.9) and this effect was dose-related (p for trend <0.001). After adjusting for oral corticosteroid exposure this odds ratio was reduced to 1.6 (95% CI 0.8 to 3.2) although the dose relation remained (p for trend 0.036).

Conclusion: People prescribed an oral or inhaled corticosteroid are at a dose-related increased risk of adrenal insufficiency although the absolute risk is small. Our analysis suggests that the increased risk in people prescribed an inhaled corticosteroid is largely due to oral corticosteroid exposure but there may be an effect of inhaled corticosteroids when they are taken at higher doses.

Keywords: adrenal insufficiency, inhaled corticosteroid


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Airwaves
Wisia Wedzicha
Thorax 2006 61: 367. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Laghi, F., Adiguzel, N., Tobin, M. J. (2009). Endocrinological derangements in COPD. Eur Respir J 34: 975-996 [Abstract] [Full Text]  
  • BERRY, M. E (2009). Adrenal Gland Disorders. radtech 81: 57-73 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs